[PTGX] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
08-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -1.72%
YoY- -84.09%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 25,722 6,189 3,647 1,560 10,781 0 0 -
PBT -20,930 -23,998 -19,904 -13,920 -7,661 -14,101 -11,747 10.10%
Tax -181 -79 176 183 0 0 4,707 -
NP -20,749 -23,998 -20,080 -14,103 -7,661 -14,101 -11,747 9.94%
Tax Rate - - - - - - - -
Total Cost 46,471 30,187 23,727 15,663 18,442 14,101 11,747 25.74%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -80.67 -387.75 -550.59 -904.04 -71.06 0.00 0.00 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.43 -0.54 -0.72 -0.58 -0.36 -0.84 -2.00 -22.59%
EPS Diluted -0.43 -0.54 -0.72 -0.58 -0.36 -0.84 -2.00 -22.59%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.